卫生保健数据源中母婴联动算法综述

IF 2.4 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Melanie H Jacobson, Alexis A Krumme, Dina M Gifkins, Andrea V Margulis, James Weaver, Kourtney J Davis
{"title":"卫生保健数据源中母婴联动算法综述","authors":"Melanie H Jacobson, Alexis A Krumme, Dina M Gifkins, Andrea V Margulis, James Weaver, Kourtney J Davis","doi":"10.1002/pds.70189","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Studies that use health care data to assess infant outcomes following maternal medication use in pregnancy require linkage of maternal and infant records. While such linkage is increasing among established and emerging data sources, linkage methods are heterogeneous and have not been thoroughly reviewed or evaluated to inform fitness for use. The objective of this study was to describe methods used to link maternal and infant records in health care databases for pharmacoepidemiology research.</p><p><strong>Methods: </strong>Multiple Medline searches were conducted using structured terms and known mother-infant linked data sources. Reference sections of identified key papers were also reviewed. From each publication, we abstracted information on the type(s) of data sources, data fields used for the linkage, linkage methodology, and any results of record linkage evaluation.</p><p><strong>Results: </strong>We reviewed 114 publications describing mother-infant linkages published from 1990 to 2025 that used data from North and South America, Europe, Asia, and Oceania. Linkage methods using administrative claims data only primarily relied on family ID and estimated dates of maternal delivery and infant birth; proportions of mothers linked with infants were 56%-90%. Use of vital records, such as birth certificates, alongside claims data resulted in higher linkage proportions (> 86% of deliveries); examples were identified in Taiwan, Europe, and several US states. Utilization of birth records together with hospital discharge data resulted in linkages of over 90% of deliveries. Linkages involving additional data types, such as electronic health records, were identified in Europe and the US. Mother-infant linkages were straightforward in regions with national birth registers that include identifiers for mother and infant, such as the Nordic countries, and within integrated delivery networks in the US that provide both health insurance and care. Although most mother-infant linkages used deterministic methods, probabilistic methods typically achieved greater linkage proportions while requiring more data fields. Validations were uncommon; two studies demonstrated high positive predictive value (> 95%) but lower sensitivity (20%-88%).</p><p><strong>Discussion: </strong>Successful mother-infant data linkage occurs throughout the world and is enabled by aligned health care and technology infrastructure and policy. To increase trust in evidence generated from linked data, we encourage researchers and journals to include a description of linking methods, a quantification of linkage success, and, when possible, an assessment of linkage validity in peer-reviewed publications.</p>","PeriodicalId":19782,"journal":{"name":"Pharmacoepidemiology and Drug Safety","volume":"34 8","pages":"e70189"},"PeriodicalIF":2.4000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Review of Mother-Infant Linkage Algorithms in Health Care Data Sources.\",\"authors\":\"Melanie H Jacobson, Alexis A Krumme, Dina M Gifkins, Andrea V Margulis, James Weaver, Kourtney J Davis\",\"doi\":\"10.1002/pds.70189\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Studies that use health care data to assess infant outcomes following maternal medication use in pregnancy require linkage of maternal and infant records. While such linkage is increasing among established and emerging data sources, linkage methods are heterogeneous and have not been thoroughly reviewed or evaluated to inform fitness for use. The objective of this study was to describe methods used to link maternal and infant records in health care databases for pharmacoepidemiology research.</p><p><strong>Methods: </strong>Multiple Medline searches were conducted using structured terms and known mother-infant linked data sources. Reference sections of identified key papers were also reviewed. From each publication, we abstracted information on the type(s) of data sources, data fields used for the linkage, linkage methodology, and any results of record linkage evaluation.</p><p><strong>Results: </strong>We reviewed 114 publications describing mother-infant linkages published from 1990 to 2025 that used data from North and South America, Europe, Asia, and Oceania. Linkage methods using administrative claims data only primarily relied on family ID and estimated dates of maternal delivery and infant birth; proportions of mothers linked with infants were 56%-90%. Use of vital records, such as birth certificates, alongside claims data resulted in higher linkage proportions (> 86% of deliveries); examples were identified in Taiwan, Europe, and several US states. Utilization of birth records together with hospital discharge data resulted in linkages of over 90% of deliveries. Linkages involving additional data types, such as electronic health records, were identified in Europe and the US. Mother-infant linkages were straightforward in regions with national birth registers that include identifiers for mother and infant, such as the Nordic countries, and within integrated delivery networks in the US that provide both health insurance and care. Although most mother-infant linkages used deterministic methods, probabilistic methods typically achieved greater linkage proportions while requiring more data fields. Validations were uncommon; two studies demonstrated high positive predictive value (> 95%) but lower sensitivity (20%-88%).</p><p><strong>Discussion: </strong>Successful mother-infant data linkage occurs throughout the world and is enabled by aligned health care and technology infrastructure and policy. To increase trust in evidence generated from linked data, we encourage researchers and journals to include a description of linking methods, a quantification of linkage success, and, when possible, an assessment of linkage validity in peer-reviewed publications.</p>\",\"PeriodicalId\":19782,\"journal\":{\"name\":\"Pharmacoepidemiology and Drug Safety\",\"volume\":\"34 8\",\"pages\":\"e70189\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacoepidemiology and Drug Safety\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pds.70189\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacoepidemiology and Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pds.70189","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

引言:研究使用卫生保健数据,以评估婴儿的结局后,在怀孕期间使用药物的母亲需要联系母婴记录。虽然这种联系在已建立的和新兴的数据源之间正在增加,但联系方法是异构的,并且尚未经过彻底的审查或评估以告知使用的适用性。本研究的目的是描述用于药物流行病学研究的卫生保健数据库中连接母婴记录的方法。方法:使用结构化术语和已知的母婴关联数据源进行多次Medline搜索。还审查了确定的关键论文的参考部分。从每份出版物中,我们提取了有关数据源类型、用于链接的数据字段、链接方法以及记录链接评估的任何结果的信息。结果:我们回顾了1990年至2025年间发表的114篇描述母婴关系的出版物,这些出版物使用了来自北美和南美、欧洲、亚洲和大洋洲的数据。使用行政索赔数据的关联方法仅主要依赖于家庭ID和估计的产妇分娩和婴儿出生日期;有孩子的母亲比例为56%-90%。将生命记录(如出生证明)与索赔数据一起使用,导致更高的关联比例(约占分娩的86%);在台湾、欧洲和美国的几个州都发现了这种情况。将出生记录与出院数据结合使用,90%以上的分娩实现了关联。在欧洲和美国发现了涉及电子健康记录等其他数据类型的联系。在北欧国家等拥有包括母婴标识符的国家出生登记的地区,以及在美国提供医疗保险和护理的综合分娩网络中,母婴联系是直接的。虽然大多数母婴联系使用确定性方法,但概率方法通常获得更大的联系比例,同时需要更多的数据字段。验证并不常见;两项研究显示较高的阳性预测值(> 95%),但较低的敏感性(20%-88%)。讨论:母婴数据连接在世界各地都取得了成功,这是通过协调一致的卫生保健和技术基础设施和政策实现的。为了增加对关联数据产生的证据的信任,我们鼓励研究人员和期刊在同行评审的出版物中包括对关联方法的描述、关联成功的量化,以及在可能的情况下对关联有效性的评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Review of Mother-Infant Linkage Algorithms in Health Care Data Sources.

Introduction: Studies that use health care data to assess infant outcomes following maternal medication use in pregnancy require linkage of maternal and infant records. While such linkage is increasing among established and emerging data sources, linkage methods are heterogeneous and have not been thoroughly reviewed or evaluated to inform fitness for use. The objective of this study was to describe methods used to link maternal and infant records in health care databases for pharmacoepidemiology research.

Methods: Multiple Medline searches were conducted using structured terms and known mother-infant linked data sources. Reference sections of identified key papers were also reviewed. From each publication, we abstracted information on the type(s) of data sources, data fields used for the linkage, linkage methodology, and any results of record linkage evaluation.

Results: We reviewed 114 publications describing mother-infant linkages published from 1990 to 2025 that used data from North and South America, Europe, Asia, and Oceania. Linkage methods using administrative claims data only primarily relied on family ID and estimated dates of maternal delivery and infant birth; proportions of mothers linked with infants were 56%-90%. Use of vital records, such as birth certificates, alongside claims data resulted in higher linkage proportions (> 86% of deliveries); examples were identified in Taiwan, Europe, and several US states. Utilization of birth records together with hospital discharge data resulted in linkages of over 90% of deliveries. Linkages involving additional data types, such as electronic health records, were identified in Europe and the US. Mother-infant linkages were straightforward in regions with national birth registers that include identifiers for mother and infant, such as the Nordic countries, and within integrated delivery networks in the US that provide both health insurance and care. Although most mother-infant linkages used deterministic methods, probabilistic methods typically achieved greater linkage proportions while requiring more data fields. Validations were uncommon; two studies demonstrated high positive predictive value (> 95%) but lower sensitivity (20%-88%).

Discussion: Successful mother-infant data linkage occurs throughout the world and is enabled by aligned health care and technology infrastructure and policy. To increase trust in evidence generated from linked data, we encourage researchers and journals to include a description of linking methods, a quantification of linkage success, and, when possible, an assessment of linkage validity in peer-reviewed publications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
7.70%
发文量
173
审稿时长
3 months
期刊介绍: The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report. Particular areas of interest include: design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology; comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world; methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology; assessments of harm versus benefit in drug therapy; patterns of drug utilization; relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines; evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信